Ovarian Cancer Archive | IOZK

A phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).

2019-05-31/in Hyperthermia, International Publications, Ovarian Cancer /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e17032)

Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer

2019-05-09/in Hyperthermia, International Publications, Ovarian Cancer /von 2019-05-09 / Jpn. J. Clin. Oncol. 2019 May;

Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

2019-04-11/in Dendritic Cells, International Publications, Ovarian Cancer /von 2019-04-11 / Front Immunol 2019;10:766

Immunotherapy in Ovarian Cancer

2019-04-05/in Dendritic Cells, International Publications, Ovarian Cancer /von 2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-464

Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.

2019-03-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2019-03-01 / J Clin Oncol 37, 2019 (suppl 8; abstr TPS10)

Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth

2018-11-14/in Cervical Cancer, Hyperthermia, International Publications, Ovarian Cancer /von 2018-11-14 / Int J Hyperthermia 2019;36(1):9-20

Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer

2018-09-11/in International Publications, Newcastle Disease Virus, Ovarian Cancer /von 2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-1638

Further clinical advancement of dendritic cell vaccination against ovarian cancer

2018-08-23/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-08-23 / Ann Res Hosp 2018 Aug;2

Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.

2018-06-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-06-01 / J Clin Oncol 36, 2018 (suppl; abstr e17515)

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer

2018-06-01/in Hyperthermia, International Publications, Ovarian Cancer /von 2018-06-01 / Open Med (Wars) 2018;13:83-89